“Sadly, none of them is interested in making drugs for rare conditions or, say, for an infectious disease in countries with no money, because it’s not a big market. Nor are they interested in developing drugs for conditions like Alzheimer’s or Parkinson’s disease because it too difficult and there’s not money to be made quickly.
“It has become interested only in the immediate, in short term gains. On Wall Street, the pharmaceutical industry is third after petrol and banking, and each year it increases by 20%. It’s more profitable than mining for diamonds.”
Please read full and follow at: